Publicaciones en las que colabora con Pedro Luis Sánchez Fernández (29)

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Date of admission during covid-19 pandemic impacted patient outcomes in addition to the higher efficacy of tocilizumab plus high-dose corticosteroid therapy compared to tocilizumab alone

    Journal of Clinical Medicine, Vol. 11, Núm. 1

  2. Retinal blood vessel calibre and vascular ageing in a general Spanish population: A EVA study

    European Journal of Clinical Investigation, Vol. 52, Núm. 2

2021

  1. Early experience in the multidisciplinary care (pediatricians and cardiologists) of adults with congenital heart disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 714-716

  2. Magnetic resonance myocardial feature tracking in transfusion-dependent myelodysplastic syndrome

    Journal of Cardiovascular Imaging, Vol. 29, Núm. 4, pp. 331-344

  3. Predictors of cardiovascular events and all-cause of death in patients with transfusion-dependent myelodysplastic syndrome

    British Journal of Haematology, Vol. 195, Núm. 4, pp. 536-541

  4. Usefulness of myocardial T1 and T2 mapping with magnetic resonance in transfusion-dependent patients with low-risk myelodysplastic syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 630-633

2020

  1. Effectiveness of sacubitril–valsartan in cancer patients with heart failure

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 763-767

  2. Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269

  3. Reference values of arterial stiffness parameters and their association with cardiovascular risk factors in the Spanish population. The EVA Study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 43-52

  4. Tricuspid regurgitation severity after atrial septal defect closure or pulmonic valve replacement

    Heart, Vol. 106, Núm. 6, pp. 455-461

2019

  1. Preconception Assessment of Women of Childbearing Age With Congenital Heart Disease

    Revista Espanola de Cardiologia, Vol. 72, Núm. 8, pp. 683-684

  2. Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy

    International Journal of Molecular Sciences, Vol. 20, Núm. 19

  3. Start-up of a Cardiology Day Hospital: Activity, Quality Care and Cost-effectiveness Analysis of the First Year of Operation

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 130-137

2018

  1. Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome

    Heart, Vol. 104, Núm. 1, pp. 45-50

  2. Síndrome de Hedinger secundario a tumor neuroendocrino ileal

    Revista de Ecocardiografía práctica y otras Técnicas de Imagen Cardíaca (RETIC), Vol. 1, Núm. 1, pp. 51-54

2017

  1. Cardiopatías congénitas

    Medicine (Spain), Vol. 12, Núm. 45, pp. 2683-2699

  2. Derrame pericárdico. Taponamiento cardíaco

    Medicine (Spain), Vol. 12, Núm. 44, pp. 2621-2628

  3. Indicaciones e interpretación de pruebas de imagen en las enfermedades pericárdicas

    Medicine (Spain), Vol. 12, Núm. 44, pp. 2638-2641

  4. Indicaciones quirúrgicas en la patología pericárdica

    Medicine (Spain), Vol. 12, Núm. 44, pp. 2650-2652